RPID

Rapid Micro Biosystems, Inc. NASDAQ Listed Jul 15, 2021

Healthcare ·Medical - Devices ·US · rapidmicrobio.com

$2.56

Mkt Cap $117.2M

52w Low $2.01 18.8% of range 52w High $4.94

50d MA $2.81 200d MA $3.29

P/E (TTM) -2.4x

EV/EBITDA -3.0x

P/B 3.4x

Debt/Equity 0.7x

ROE -141.9%

P/FCF -4.1x

RSI (14) —

ATR (14) —

Beta 1.60

50d MA $2.81

200d MA $3.29

Avg Volume 215.9K

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

SIC Code

3826

CIK (SEC)

1380106

Phone

978 349 3200

1001 Pawtucket Boulevard West · Lowell, MA 01854 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 12, 2026	AMC	-0.23	-0.28	-21.7%	3.43	+3.2%	-17.5%	+4.9%	-1.7%	-8.2%	-6.7%	—
Nov 7, 2025	AMC	-0.26	-0.26	+0.0%	3.10	+1.0%	+4.5%	+16.0%	+10.1%	+7.7%	-5.6%	—
Aug 12, 2025	AMC	-0.26	-0.27	-3.8%	2.68	-3.0%	+8.6%	-3.1%	-7.1%	+1.1%	-7.2%	—
May 9, 2025	AMC	-0.27	-0.26	+3.7%	3.08	-2.6%	-5.2%	+8.2%	-5.1%	+2.0%	+4.9%	—
Feb 28, 2025	AMC	-0.22	-0.22	+0.0%	3.05	-3.6%	-15.1%	-4.6%	+10.1%	-3.7%	-8.8%	—
Nov 1, 2024	AMC	-0.26	-0.26	+0.0%	1.10	-0.9%	-1.8%	+0.9%	+4.6%	+8.8%	+1.6%	—
Aug 2, 2024	AMC	-0.28	-0.29	-3.6%	0.80	-0.6%	-0.8%	-1.0%	-4.0%	+13.4%	-0.0%	—
May 3, 2024	AMC	-0.29	-0.31	-6.9%	0.89	+3.3%	-1.5%	-1.9%	-7.4%	+1.0%	-0.6%	—
Mar 1, 2024	AMC	-0.31	-0.26	+16.1%	0.98	+4.1%	+1.0%	+0.0%	+1.0%	-2.1%	+0.2%	—
Nov 3, 2023	AMC	-0.32	-0.31	+3.1%	1.09	+5.5%	-3.7%	-3.8%	+1.0%	-3.4%	-1.3%	—
Aug 4, 2023	AMC	-0.36	-0.33	+8.3%	0.92	+2.2%	-2.2%	+1.1%	-2.2%	+5.5%	-1.2%	—
May 5, 2023	AMC	-0.36	-0.32	+11.1%	0.89	+0.0%	-6.7%	+6.0%	+0.0%	+0.0%	+2.9%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 7	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$1.28	$1.26	-1.6%	+9.4%	-9.3%	-2.4%	-6.5%	-5.2%
Aug 16	JP Morgan	Downgrade	Overweight → Neutral	—	$3.83	$3.69	-3.7%	-8.6%	+1.7%	-7.3%	-8.2%	-2.6%
May 11	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$4.46	$4.35	-2.5%	-12.8%	-3.3%	+6.4%	-4.5%	+11.3%
Mar 7	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$5.76	$5.73	-0.5%	+0.2%	+4.2%	+12.6%	-7.2%	-0.2%
Feb 15	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$7.31	$7.47	+2.2%	+7.0%	-0.1%	-9.9%	+2.0%	-1.7%
Nov 15	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$17.23	$17.24	+0.1%	-4.5%	+1.2%	-1.1%	-1.3%	-1.6%
Aug 9	Cowen & Co.	Maintains	Outperform → Outperform	—	$23.35	$23.02	-1.4%	-4.5%	-3.1%	+0.1%	-14.7%	+2.8%
Aug 9	JP Morgan	Maintains	Overweight → Overweight	—	$23.35	$23.02	-1.4%	-4.5%	-3.1%	+0.1%	-14.7%	+2.8%
Aug 9	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$23.35	$23.02	-1.4%	-4.5%	-3.1%	+0.1%	-14.7%	+2.8%
Aug 9	Stifel	Maintains	Buy → Buy	—	$23.35	$23.02	-1.4%	-4.5%	-3.1%	+0.1%	-14.7%	+2.8%

Data updated apr 26, 2026 11:28pm · Source: massive.com